Page last updated: 2024-08-22

isopentenyladenosine and Malignant Melanoma

isopentenyladenosine has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amodio, G; Bifulco, M; Ciaglia, E; Gazzerro, P; Laezza, C; Picardi, P; Pisanti, S; Proto, MC; Ranieri, R; Remondelli, P	1

Other Studies

1 other study(ies) available for isopentenyladenosine and Malignant Melanoma

Article	Year
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux. Cell death and differentiation, 2018, Volume: 25, Issue:2 Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isopentenyladenosine; Melanoma; Mice; Mice, Nude; Mice, SCID; Neoplasms, Experimental; Prenylation; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins; Tumor Cells, Cultured	2018

Article

Year

N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.

Cell death and differentiation, 2018, Volume: 25, Issue:2

Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isopentenyladenosine; Melanoma; Mice; Mice, Nude; Mice, SCID; Neoplasms, Experimental; Prenylation; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins; Tumor Cells, Cultured

2018